- Advertise
- Contact Us
- Contribute
- Editorial Info
- Terms and Conditions
- Privacy Policy
- Do Not Sell My Personal Information
- About Us
© 2021 MJH Life Sciences™ and Endocrinology Network. All rights reserved.
Diabetes
The Endocrinology Network® Diabetes clinical resource center offers readers the very latest news and information related to diabetes management. Including content related to type 1 diabetes, type 2 diabetes, and gestational diabetes, the diabetes clinical resource center hosts information on FDA approvals, the latest studies, and practice updates for clinicians practicing in the field of endocrinology.
Treating Polycystic Ovary Syndrome Costs $8 Billion in US Annually
September 22, 2021
A meta-analysis builds upon previous research and provides new insight into the total costs of diagnosis and treating PCOS as well as the costs of treating PCOS-related comorbidities.
FDA Approves Byooviz, First Biosimilar to Treat Macular Edema and Other Eye Conditions
September 21, 2021
The approval, which was announced in a statement on September 20, makes Byooviz (ranibizumab-nuna) the first biosimilar to Lucentis (ranibizumab injection) for the treatment of several eye diseases and conditions.
Greater Adherence to Diabetes Guidelines Needed in US Medical Practices
September 17, 2021
Jennifer Green, MD, explains how delays in the adoption of new guideline recommendations are holding back optimal management of type 2 diabetes in the US.
Improving Awareness and Management of Gestational Diabetes, With Erica Gunderson, PhD
September 16, 2021
Erica P. Gunderson, PhD, MS, MPH, offers perspective on the current state of gestational diabetes management as well as avenues for improving current diagnostic and management standards.
Reflecting on 100 Years of Insulin, With Vivian Fonseca, MD
September 16, 2021
Vivian Fonseca, MD, reflects on the 100-year anniversary of the discovery of insulin and how the role of insulin has evolved since Sir Frederick Banting's historic discovery.
Silvio Inzucchi, MD: Stroke Prevention and Diabetes Medications
September 14, 2021
Silvio Inzucchi, MD, discusses his presentation on the role of diabetes medications, including SGLT2 inhibitors and GLP-1 RAs, in stroke prevention from TMIOA's 5th Heart in Diabetes conference.
Pharmacist-Led Dietary Interventions Could Contribute to Diabetes Remission
September 13, 2021
A 12-week trial assessing the effects of a low calorie, low carbohydrate diet facilitated by community pharmacists suggests this approach could contribute to the remission of type 2 diabetes in adult patients.
Polyunsaturated Fatty Acids Could Protect Against Diabetic Eye Disease
September 10, 2021
A 3-year study with more than 500 patients, results suggest none of the study participants had a BCVA worse than 0.3 (log MAR 0.48) due to diabetic retinopathy.
FDA Warns 10 Companies For Illegally Marketing Supplements Claiming to Treat Diabetes
September 09, 2021
The FDA and FTC posted warnings to 10 companies for violating the Federal Food, Drug, and Cosmetic Act by selling dietary supplements claiming to cure, treat, mitigate, or prevent diabetes.
Patients with Diabetes More Likely to Experience Sexual Dysfunction
September 04, 2021
New data describes risk factors associated with increased prevalence of sexual dysfunction among patients with type 1 and type 2 diabetes.